Blue Horseshoe Stocks: Kicking Off the Short Week

INSYS Therapeutics, Inc. INSY

This morning we kick off the holiday shortened week, during a time of year that typically sees subdued activity for the markets as a whole, as people spend time with their families, and stay busy with holiday festivities.

We still strive to identify possible opportunities even in this environment, and the first thing to hit our scanner this morning was INSY. INSYS Therapeutics recently initiated Phase II trials of its synthetic Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy.

The FDA, we’re learning today, has also granted Fast Track status to INSY for the ‘drug’ for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder. (View PR)

The stock registered its 52-week lows at the beginning of last month, and has been in a general uptrend since, but we’ll be looking for further bullish activity on the heels of this FDA news, both on the stock chart, and in the options chain as a secondary idea. For that, we’ll look to the INSY 01/19 $8 & $9 Calls for opportunities.


DelMar Pharmaceuticals, Inc. DMPI

Speaking of FDA Fast Track designations, we’re looking to DMPI this morning as well, which was granted the status by the FDA for its lead-product cancer treatment, VAL-083.

The chart itself was already set up as a possible bottom play, and despite gapping up considerably on this morning’s news, there is still room to the upside, including a sizable gap that’s been left on the chart since this past spring, the eventual filling of which would spell gains of more than 100% from the current PPS.


Extended Watchlist:
KLXI, EXXI, AEZS, SRAX, IMUC, NETE

Blue Horseshoe Stocks: AMRS, TTOO Recaps & More

 Cracker Barrel Old Country Store, Inc. CBRL

We were looking at a favorable setup on the CBRL chart along with a premarket earning beat in yesterday morning’s report, and we floated a couple of options ideas that worked out pretty well early on in the session.

We had the CBRL Weekly $150 & 151.50 Calls as well as the 10/20 $155 Calls on watch, and both our short -term and longer-term ideas provided excellent chances for multi-bag gains on the day.

The Weekly $150′s traded in a range from 1.01-4.00 (+296%), while the
$151.50′s ran from 1.10-2.79, gaining 154% intraday. Even the longer-term idea, the 10/20 $155′s more than doubled on the day, running 175% from 1.09-3.00.


Amyris, Inc. AMRS

We wanted to circle back for AMRS today to recap the past month of its performance on the chart. We put this play on bottom-watch on the morning of  August 15th, and as it turns out, our timing was pretty good. It was just a couple of sessions later when we observed a low of 1.86  in the stock, and it’s been mostly bullish moves since then.

Yesterday, AMRS hit a new high of 3.84, marking an overall increase of 106% in matter of just one month’s time. If the stock can manage to break its previous resistance around the 4.30 area, things could get really interesting.

______

Added Note:

T2 Biosystems, Inc. TTOO - In that same report from August 15th we were discussing the run we had seen from TTOO from 2.53 to its highs at the time just over $4. It too hit an impressive new high yesterday, at 6.99. That works out to a one month increase of 176%


Extended Watchlist:
ICNB, ONCI, TOPS, ALV, ALDX, IMUC,

Blue Horseshoe Stocks: Retail Focus

Retail Focus

Macy’s, Inc. M - With the holiday season fast approaching, we’ll be on the lookout for retail plays with good upside potential, and Macy’s could be a good fit in that regard.

You can take a look at the chart below and see that the stock has just begun to show signs of a rebound after getting absolutely hammered earlier this month. Indicators suggest that the stock is rather oversold.

We’re going to radar a set of longer-term contracts, the M 11/17 $23 Calls, which should see a nice move if the stock can indeed regain the ground it’s lost over the past few weeks. There’s also a gap on the chart to the $28 area, the filling of which would propel those contracts to huge gains.


______

JC Penney Co. Inc. JCP - Another retailer we’ve talked about many times in the past, particularly leading up to and during the holidays, is JCP.

Similar to the above mentioned play, the stock took a punishing hit to its PPS over the past few weeks, and has shown the beginnings of a rebound. It has an even larger gap on the chart, and a chance to fill it even quicker.

The stock itself could end up being a good recovery play, but we’ll also want to put a couple sets of options contracts on watch as well, with the JCP 11/17 $4 and 4.50 Calls.


______

More Retail Ideas – Also in the retail sector, and each with premarket earnings beats, are American Eagle Outfitters, Inc. AEO and Express, Inc. EXPR. We’re going to radar the AEO Weekly $12 & 12.50 Calls, and the EXPR 09/15 $6 & $7 Calls.


Zion Oil & Gas, Inc. ZN

We also wanted to quickly update readers on the performance of ZN, after it was a topic of discussion in yesterday’s premarket report. While the stock didn’t break out by any means, it did trade from a low of 2.95 to a high of 3.42 for a modest 16% intraday move.

It did, however, manage to close just two cents below its high of day, so we’ll have it on continued watch this midweek, looking for the recording of higher highs and higher lows.


Extended Watchlist:
BLKG, RMRK, IMUC, NVAX, SCYX, DXTR,

Blue Horseshoe Stocks: Updates, Bottom-Plays & More


Aeterna Zentaris, Inc. AEZS

We flagged AEZS on Wednesday’s morning, and saw rip its way to nearly a 90% gain. Then yesterday morning, we took note of the heavy volume and kept the stock on our radar.

It didn’t quite match the degree of the previous session’s move, but still followed it up with a solid performance, running from 2.55 to 3.29 on the day. That’s an intraday spike of 29% and a two-day upswing of 122% over our observed low of 1.48,  while volume was massive once again. We’ll be looking for AEZS to possibly continue its multi-day run, and would want to see maintain support at or above Wednesday’s closing price of 2.34 on any pullbacks, in order to remain interested.


ImmunoCellular Therapeutics, Ltd. IMUC

We want to radar IMUC as a bottom-watch play this morning. We noticed the stock had fallen to a new annual low yesterday, following the pricing of a public offering earlier this week, that is expected to be executed today.

We’re always on the lookout for battered stocks that could become rebound play candidates, and we’re always looking for charts with gaps to the upside and IMUC currently checks both of those boxes.


Extended Watchlist:
PPHM, OTTV, TVIA, OPGN, TXMD, FTR, MBRX, PLUG

Blue Horseshoe Stocks: MSDI Recap, PEP Options & More

Monster Digital, Inc. MSDI

We re-tagged MSDI for observation in yesterday morning’s premarket watchlist, and the stock ended up making a pretty good jump right out of the starting gate on a surge of huge volume to new new highs. This is a play that we first mentioned a few weeks back on June 19th, when it was trading in the .40-.50 range.

Yesterday it initially ran from 1.53 to its new high of 2.35 for an intraday swing of 54% though it didn’t manage to hold much of its advance into the close. Still, when all was said and done, MSDI ended up being the NASDAQ’s top gainer of the day, traded nearly sixty times its monthly average volume, and extended our total observed range since our first alert to a very respectable 408%



Pepsico, Inc. PEP – Options Ideas

Pepsi has been on a bit of a downturn of late, and despite its bearish moves of the past couple of weeks, we took notice of the fact that it has come down to rest around its 50-day moving average. The last time the stock spent any appreciable amount of time trading below that average, was more than four months ago.

Compound that with a chance for a boost from its scheduled quarterly earnings call next week (07/11), and it makes us interested to track some PEP options on the chance that the stock makes a rebound as we suspect it might.

We’ll take a look at the PEP Weekly $115 Calls for potential day/swing trades this week, and keep tabs on the PEP 07/14 $116 and $117 Calls in the event of a run into and/or following earnings this coming Tuesday.


Extended Watchlist:
PGLC, IMUC, FRO, KTOV, UHLN, IMTV